check_circleStudy Completed

Contraception, Ovulation Inhibition, Contraceptives, Oral

Bayer Identifier:

90369

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to compare cycle control and safety of the oral contraceptive SH T 00186 D (0.02 mg Ethinylestradiol and 3 mg Drospirenone) in a 21-day regimen vs. Mercilon®

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
441
Trial Dates
February 2001 - May 2002
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Yasminelle (EE20/DRSP, BAY86-5300)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Multi-center, open, randomized, parallel group comparison of cycle control and safety of the oral contraceptive SH T 00186 D (Ethinylestradiol-ß-Cyclodextrin Clathrate (equivalent to 0.02 mg ethinylestradiol) and 3 mg drospirenone) in a 21-day regimen vs. Mercilon® for 7 cycles in 400 healthy female volunteers
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.